3–6 Months | 15–18 Months | |||||
---|---|---|---|---|---|---|
HydroCoil (No.) (%) | Bare Platinum (No.) (%) | P | HydroCoil (No.) (%) | Bare Platinum (No.) (%) | P | |
No. of patients with angiographic follow-up | 114 | 115 | – | 113 | 120 | – |
No. of patients with clinical follow-up | 124 | 119 | – | 128 | 129 | – |
Any recurrence | 23 (20.2) | 35 (33.3) | .03a | 40 (35.4) | 55 (45.8) | .11 |
Major recurrence | 11 (9.6) | 17 (16.2) | 0.16 | 21 (18.6) | 37 (30.8) | .03a |
Retreatment | 1 (0.9) | 2 (1.7) | 1.0 | 3 (2.7) | 5 (4.2) | .72 |
mRS ≤ 2 | 107 (86.3) | 106 (89.1) | .56 | 113 (88.3) | 116 (89.9) | .69 |
↵a Significant.